Literature DB >> 17126901

The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.

Xiudong Liu1, Kenneth A Howard, Mingdong Dong, Morten Ø Andersen, Ulrik L Rahbek, Mads G Johnsen, Ole C Hansen, Flemming Besenbacher, Jørgen Kjems.   

Abstract

We have previously introduced the use of the biomaterial chitosan to form chitosan/siRNA nanoparticles for gene silencing protocols. This present study shows that the physicochemical properties (size, zeta potential, morphology and complex stability) and in vitro gene silencing of chitosan/siRNA nanoparticles are strongly dependent on chitosan molecular weight (Mw) and degree of deacetylation (DD). High Mw and DD chitosan resulted in the formation of discrete stable nanoparticles approximately 200 nm in size. Chitosan/siRNA formulations (N:P 50) prepared with low Mw (approximately 10 kDa) showed almost no knockdown of endogenous enhanced green fluorescent protein (EGFP) in H1299 human lung carcinoma cells, whereas those prepared from higher Mw (64.8-170 kDa) and DD (approximately 80%) showed greater gene silencing ranging between 45% and 65%. The highest gene silencing efficiency (80%) was achieved using chitosan/siRNA nanoparticles at N:P 150 using higher Mw (114 and 170 kDa) and DD (84%) that correlated with formation of stable nanoparticles of approximately 200 nm. In conclusion, this work confirms the application of chitosan as a non-viral carrier for siRNA and the importance of polymeric properties for the optimisation of gene silencing using chitosan/siRNA nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17126901     DOI: 10.1016/j.biomaterials.2006.11.004

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  78 in total

1.  Targeted gene silencing using RGD-labeled chitosan nanoparticles.

Authors:  Hee Dong Han; Lingegowda S Mangala; Jeong Won Lee; Mian M K Shahzad; Hye Sun Kim; Deyu Shen; Eun Ji Nam; Edna M Mora; Rebecca L Stone; Chunhua Lu; Sun Joo Lee; Ju Won Roh; Alpa M Nick; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Clin Cancer Res       Date:  2010-06-10       Impact factor: 12.531

2.  SYBR Gold Fluorescence Quenching is a Sensitive Probe of Chitosan-microRNA Interactions.

Authors:  Beatriz Santos-Carballal; Musti J Swamy; Bruno M Moerschbacher; Francisco M Goycoolea
Journal:  J Fluoresc       Date:  2015-10-28       Impact factor: 2.217

3.  Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Blake Goodman; Hee-Dong Han; Alpa M Nick; Rebecca L Stone; Robert L Coleman; Ronald D Alvarez; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen
Journal:  Clin Cancer Res       Date:  2011-07-13       Impact factor: 12.531

Review 4.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

5.  The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice.

Authors:  Shan Gao; Frederik Dagnaes-Hansen; Ebbe Juel Bech Nielsen; Jesper Wengel; Flemming Besenbacher; Kenneth Alan Howard; Jørgen Kjems
Journal:  Mol Ther       Date:  2009-04-28       Impact factor: 11.454

6.  Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.

Authors:  Ana Vanessa Nascimento; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Acta Biomater       Date:  2016-09-30       Impact factor: 8.947

Review 7.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

8.  Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery.

Authors:  Theerasak Rojanarata; Praneet Opanasopit; Sunee Techaarpornkul; Tanasait Ngawhirunpat; Uracha Ruktanonchai
Journal:  Pharm Res       Date:  2008-06-18       Impact factor: 4.200

9.  Chitosan-mediated siRNA delivery in vitro: effect of polymer molecular weight, concentration and salt forms.

Authors:  Sunee Techaarpornkul; Sirirat Wongkupasert; Praneet Opanasopit; Auayporn Apirakaramwong; Jurairat Nunthanid; Uracha Ruktanonchai
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

10.  Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.

Authors:  You-Qing Cai; Shao-Rui Chen; Hee-Dong Han; Anil K Sood; Gabriel Lopez-Berestein; Hui-Lin Pan
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.